Oyster Point

FDA Accepts NDA for Oyster Point’s Dry Eye Therapy OC-01
BioSpace
Tue, 03/2/21 - 11:56 pm
Oyster Point
OC-01
dry eye disease
FDA
Amid lab space scarcity, a life sciences complex to rise in South San Francisco hub
Endpoints
Fri, 05/8/20 - 10:28 am
biotech
Oyster Point
San Francisco
California
Oyster Point raises $93M series B to bring dry eye nasal spray to FDA
BioCentury
Tue, 02/26/19 - 09:38 am
Oyster Point
dry eye disease
OC-01
OC-02
AbbVie hatches plans for a major new R&D hub close to its partners in Bay Area's buzzy Oyster Point
Endpoints
Thu, 11/8/18 - 12:09 pm
AbbVie
San Francisco
Oyster Point
biotech
Oyster Point's OC-01 dry eye nasal spray meets in Phase IIb
BioCentury
Wed, 10/24/18 - 10:16 am
Oyster Point
dry eye disease
OC-01
clinical trials
Hoping to shake Allergan/Shire’s dry eye dominance, Oyster Point posts positive Phase IIb data for rival drug
Endpoints
Thu, 07/12/18 - 11:49 am
Oyster Point
OC-02
dry eye disease
Allergan
Restasis
Shire
Xiidra